Richard Slansky

2017 - OncoSec Medical

In 2017, Richard Slansky earned a total compensation of $520.5K as Chief Financial Officer at OncoSec Medical, a 41% decrease compared to previous year.

Compensation breakdown

Option Awards$86,869
Salary$299,616
Stock Awards$134,000
Total$520,485

Slansky received $299.6K in salary, accounting for 58% of the total pay in 2017.

Slansky also received $86.9K in option awards and $134K in stock awards.

Rankings

In 2017, Richard Slansky's compensation ranked 11,700th out of 14,666 executives tracked by ExecPay. In other words, Slansky earned more than 20.2% of executives.

ClassificationRankingPercentile
All
11,700
out of 14,666
20th
Division
Manufacturing
4,595
out of 5,768
20th
Major group
Chemicals And Allied Products
1,679
out of 2,074
19th
Industry group
Drugs
1,389
out of 1,730
20th
Industry
Pharmaceutical Preparations
1,084
out of 1,329
18th
Source: SEC filing on November 28, 2017.

Slansky's colleagues

We found two more compensation records of executives who worked with Richard Slansky at OncoSec Medical in 2017.

2017

Sharron Gargosky

OncoSec Medical

Chief Clinical and Regulatory Officer

2017

Punit Dhillon

OncoSec Medical

Chief Executive Officer

News

You may also like